Providemus alz: Ubiquitous Preclinical Alzheimer’s Disease Early Screening

Providemus alz will leverage personal portable and wearable devices, such as smartphones and consumer-grade smartwatches, to facilitate digital biomarkers for early and ubiquitous detection of subtle changes when preclinical Alzheimer's disease starts. Due to the choice of continuous and longitudinal data sources, it is intended to analyze the collected data using advanced machine learning models. That will result in a ubiquitous and highly scalable solution to detect the first changes in individuals who will later develop dementia due to Alzheimer's disease.